CYP 18.4% 20.0¢ cynata therapeutics limited

At $24 million mkt cap CYP is a stupidly cheap stock.....by any measure, page-5

  1. 7,023 Posts.
    lightbulb Created with Sketch. 1293
    How's the P2 FDA trial for GVHD progressing?

    That's what the CR was for, wasn't it?




    Ross said that GVHD was likely to be the first to commercialise for CYP, remember?

    As such, that will be the first revenue that is likely to have the SP rise, wouldn't it?




    These questions are stupid?
 
watchlist Created with Sketch. Add CYP (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.